About BeamLine Diagnostics
BeamLine Diagnostics is a company based in London (United Kingdom) founded in 2015 by Katie Oliver. It operates as a B2B. BeamLine Diagnostics has raised $1.08 million across 2 funding rounds from investors including Angels in MedCity, Angel Academe and LCIF. The company has 7 employees as of March 31, 2020. BeamLine Diagnostics operates in a competitive market with competitors including PAVmed, Cyted, Previse, Lucid Diagnostics and CapNostics, among others.
- Headquarter London, United Kingdom
- Employees 7 as on 31 Mar, 2020
- Founders Katie Oliver
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Beamline Diagnostics Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.08 M (USD)
in 2 rounds
-
Latest Funding Round
$837.86 K (USD), Seed
Jun 06, 2017
-
Investors
Angels in MedCity
& 3 more
-
Employee Count
7
as on Mar 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BeamLine Diagnostics
BeamLine Diagnostics has successfully raised a total of $1.08M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $837.86 thousand completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $837,863
-
First Round
First Round
(30 Apr 2016)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2017 | Amount | Seed - BeamLine Diagnostics | Valuation | Angels in MedCity | |
| Apr, 2016 | Amount | Seed - BeamLine Diagnostics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BeamLine Diagnostics
BeamLine Diagnostics has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Angels in MedCity, Angel Academe and LCIF. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Angel Academe is focused on supporting female founders through investments.
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on digital, science, and technology sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BeamLine Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BeamLine Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Beamline Diagnostics Comparisons
Competitors of BeamLine Diagnostics
BeamLine Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PAVmed, Cyted, Previse, Lucid Diagnostics and CapNostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of medical devices and biomarkers to detect various diseases
|
|
| domain | founded_year | HQ Location |
Non-endoscopic diagnostics for early gastrointestinal disease detection are developed.
|
|
| domain | founded_year | HQ Location |
Cancer detection and prevention solutions are developed by Previse.
|
|
| domain | founded_year | HQ Location |
Diagnostic kits for esophageal cancer biomarkers are developed.
|
|
| domain | founded_year | HQ Location |
FDA-cleared swallowable device is used for non-endoscopic GI screening.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about BeamLine Diagnostics
When was BeamLine Diagnostics founded?
BeamLine Diagnostics was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is BeamLine Diagnostics located?
BeamLine Diagnostics is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Is BeamLine Diagnostics a funded company?
BeamLine Diagnostics is a funded company, having raised a total of $1.08M across 2 funding rounds to date. The company's 1st funding round was a Seed of $240K, raised on Apr 30, 2016.
How many employees does BeamLine Diagnostics have?
As of Mar 31, 2020, the latest employee count at BeamLine Diagnostics is 7.
What does BeamLine Diagnostics do?
BeamLine Diagnostics offers bedside pre-screening technology solutions for cancer detection through providing healthcare solutions, developing medical devices, offering diagnostic solutions, and cancer screening. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Who are the top competitors of BeamLine Diagnostics?
BeamLine Diagnostics's top competitors include Lucid Diagnostics, PAVmed and Previse.
Who are BeamLine Diagnostics's investors?
BeamLine Diagnostics has 4 investors. Key investors include Angels in MedCity, Angel Academe, LCIF, and Deepbridge Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.